spiradoline has been researched along with Arrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, ES; Kramer, D; Pugsley, MK; Saint, DA; Walker, MJ | 1 |
| Lishmanov, YB; Maslov, LN; Ugdyzhekova, DS | 1 |
2 other study(ies) available for spiradoline and Arrhythmia
| Article | Year |
|---|---|
Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Patch-Clamp Techniques; Potassium Channels; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sodium Channel Blockers | 1998 |
Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Benzomorphans; Dynorphins; Male; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1999 |